Barry P. Flannelly, EVP and General Manager US at Incyte Corp ($INCY), sold about $2.26 million in company shares across six open market transactions over the last year. His most recent sale occurred on July 16, 2025. These sales rank 3,256th among 11,678 individual insiders in our database, where the average is about $8.6 million per seller over roughly six trades. Flannelly made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 16, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 1340 | $68.36 | 35,149.0000 | 210,530,000 | 3.67% | 0.00% |
| July 15, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 1141 | $68.25 | 36,489.0000 | 210,530,000 | 3.03% | 0.00% |
| July 15, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 1192 | $69.86 | 37,630.0000 | 210,530,000 | 3.07% | 0.00% |
| July 14, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 922 | $69.98 | 38,822.0000 | 210,530,000 | 2.32% | 0.00% |
| July 3, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 10903 | $68.15 | 39,744.0000 | 210,530,000 | 21.53% | 0.01% |
| July 2, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 9055 | $68.17 | 50,647.0000 | 210,530,000 | 15.17% | 0.00% |
| June 12, 2025 | Protara Therapeutics, Inc. | $PRTO | Flannelly Barry P | Not found | A | Stock Option (Right to Buy) | 24000 | $0.00 | 24,000.0000 | 40,707,937 | 9999.99% | 0.06% |
| April 1, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | A | Common Stock | 14976 | $0.00 | 59,702.0000 | 210,530,000 | 33.48% | 0.01% |
| April 1, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | A | Common Stock | 11159 | $0.00 | 44,726.0000 | 210,530,000 | 33.24% | 0.01% |
| March 14, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 199 | $67.88 | 52,714.0000 | 210,530,000 | 0.38% | 0.00% |
| March 14, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 19147 | $67.68 | 33,567.0000 | 210,530,000 | 36.32% | 0.01% |
| March 14, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 461 | $67.85 | 52,913.0000 | 210,530,000 | 0.86% | 0.00% |
| Jan. 17, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | A | Employee Stock Option (right to buy) | 20144 | $0.00 | 20,144.0000 | 210,530,000 | 9999.99% | 0.01% |
| Jan. 15, 2025 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 3158 | $72.46 | 53,374.0000 | 210,530,000 | 5.59% | 0.00% |
| Dec. 9, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 1510 | $72.11 | 56,532.0000 | 211,763,000 | 2.60% | 0.00% |
| Nov. 6, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 1424 | $82.00 | 60,298.0000 | 211,763,000 | 2.31% | 0.00% |
| Nov. 6, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | M | Common Stock | 1424 | $72.27 | 59,466.0000 | 211,763,000 | 2.45% | 0.00% |
| Nov. 6, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | M | Common Stock | 2256 | $68.62 | 61,722.0000 | 211,763,000 | 3.79% | 0.00% |
| Nov. 6, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 2256 | $78.21 | 58,042.0000 | 211,763,000 | 3.74% | 0.00% |
| Nov. 6, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | M | Employee Stock Option (right to buy) | 1424 | $0.00 | 0.0000 | 211,763,000 | 100.00% | 0.00% |
| Nov. 6, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | M | Employee Stock Option (right to buy) | 2256 | $0.00 | 0.0000 | 211,763,000 | 100.00% | 0.00% |
| July 15, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | A | Common Stock | 9925 | $0.00 | 60,459.0000 | 225,928,000 | 19.64% | 0.00% |
| July 16, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 1306 | $64.19 | 58,042.0000 | 225,928,000 | 2.20% | 0.00% |
| July 15, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | A | Employee Stock Option (right to buy) | 22205 | $0.00 | 22,205.0000 | 225,928,000 | 9999.99% | 0.01% |
| July 15, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 1111 | $64.25 | 59,348.0000 | 225,928,000 | 1.84% | 0.00% |
| July 9, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 8148 | $60.00 | 50,534.0000 | 225,928,000 | 13.89% | 0.00% |
| July 2, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 7695 | $59.02 | 58,682.0000 | 225,928,000 | 11.59% | 0.00% |
| June 12, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | S | Common Stock | 19164 | $60.00 | 66,377.0000 | 225,928,000 | 22.40% | 0.01% |
| June 7, 2024 | Protara Therapeutics, Inc. | $PRTO | Flannelly Barry P | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 11,420,948 | 9999.99% | 0.09% |
| Feb. 14, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | A | Common Stock | 7377 | $0.00 | 85,080.0000 | 225,928,000 | 9.49% | 0.00% |
| Jan. 18, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | A | Employee Stock Option (right to buy) | 21843 | $0.00 | 21,843.0000 | 225,928,000 | 9999.99% | 0.01% |
| Jan. 17, 2024 | INCYTE CORP | $INCY | Flannelly Barry P | EVP & General Manager US | F | Common Stock | 3675 | $61.48 | 77,703.0000 | 225,928,000 | 4.52% | 0.00% |